These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26618648)

  • 1. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
    Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
    Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study.
    Nakagawa H; Koizumi N; Okumura N; Suganami H; Kinoshita S
    PLoS One; 2015; 10(9):e0136802. PubMed ID: 26367375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil).
    Schlötzer-Schrehardt U; Zenkel M; Strunz M; Gießl A; Schondorf H; da Silva H; Schmidt GA; Greiner MA; Okumura N; Koizumi N; Kinoshita S; Tourtas T; Kruse FE
    Am J Ophthalmol; 2021 Apr; 224():185-199. PubMed ID: 33316261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.
    Moloney G; Garcerant Congote D; Hirnschall N; Arsiwalla T; Luiza Mylla Boso A; Toalster N; D'Souza M; Devasahayam RN
    Cornea; 2021 Mar; 40(3):320-326. PubMed ID: 32740006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.
    Moloney G; Petsoglou C; Ball M; Kerdraon Y; Höllhumer R; Spiteri N; Beheregaray S; Hampson J; DʼSouza M; Devasahayam RN
    Cornea; 2017 Jun; 36(6):642-648. PubMed ID: 28476048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet's Stripping Only Model.
    Parekh M; Miall A; Chou A; Buhl L; Deshpande N; Price MO; Price FW; Jurkunas UV
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy.
    Koizumi N; Okumura N; Ueno M; Nakagawa H; Hamuro J; Kinoshita S
    Cornea; 2013 Aug; 32(8):1167-70. PubMed ID: 23715376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.
    Macsai MS; Shiloach M
    Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops.
    Koizumi N; Okumura N; Ueno M; Kinoshita S
    Cornea; 2014 Nov; 33 Suppl 11():S25-31. PubMed ID: 25289721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.
    Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy.
    Kinoshita S; Colby KA; Kruse FE
    Cornea; 2021 Oct; 40(10):1225-1228. PubMed ID: 34481406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.
    Ohta Y; Takaseki S; Yoshitomi T
    Jpn J Ophthalmol; 2017 Sep; 61(5):423-432. PubMed ID: 28653193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia.
    Yamaguchi M; Nakao S; Arita R; Kaizu Y; Arima M; Zhou Y; Kita T; Yoshida S; Kimura K; Isobe T; Kaneko Y; Sonoda KH; Ishibashi T
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2264-76. PubMed ID: 27124322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in corneal endothelial cell shape after treatment with one drop of ROCK inhibitor.
    Matsumura R; Inoue K; Shiokawa M; Ono M; Tanihara H; Ishida K; Tomita G
    Int Ophthalmol; 2020 Feb; 40(2):411-417. PubMed ID: 31664638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease.
    Syed ZA; Rapuano CJ
    Curr Opin Ophthalmol; 2021 May; 32(3):268-274. PubMed ID: 33606407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Rho Kinase Inhibitor Y-27632 on Corneal Endothelial Wound Healing.
    Okumura N; Inoue R; Okazaki Y; Nakano S; Nakagawa H; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6067-74. PubMed ID: 26393474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation.
    Maruyama Y; Ikeda Y; Mori K; Yoshii K; Ueno M; Yoshikawa H; Sotozono C; Kinoshita S
    Br J Ophthalmol; 2021 Feb; 105(2):169-173. PubMed ID: 32269062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphologic characteristics of cornea in Fuchs endothelial dystrophy observed by confocal microscopy].
    Dong WL; Zou LH; Pan ZQ; Wang L
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):465-70. PubMed ID: 15454061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on ripasudil for the treatment of glaucoma and ocular hypertension.
    Testa V; Ferro Desideri L; Della Giustina P; Traverso CE; Iester M
    Drugs Today (Barc); 2020 Sep; 56(9):599-608. PubMed ID: 33025953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.